Dr. Agarwal's Eye [DRAGARWQ] vs Max Healthcare [MAXHEALTH] Detailed Stock Comparison

Dr. Agarwal's Eye

BSE
Loading...

Max Healthcare

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Agarwal's Eye wins in 13 metrics, Max Healthcare wins in 7 metrics, with 0 ties. Dr. Agarwal's Eye appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricDr. Agarwal's EyeMax HealthcareBetter
P/E Ratio (TTM)40.3595.12Dr. Agarwal's Eye
Price-to-Book Ratio11.1411.52Dr. Agarwal's Eye
Debt-to-Equity Ratio158.9432.09Max Healthcare
PEG Ratio1.813.12Dr. Agarwal's Eye
EV/EBITDA20.3256.31Dr. Agarwal's Eye
Profit Margin (TTM)13.96%15.27%Max Healthcare
Operating Margin (TTM)22.71%20.65%Dr. Agarwal's Eye
EBITDA Margin (TTM)22.71%20.65%Dr. Agarwal's Eye
Return on Equity26.07%11.47%Dr. Agarwal's Eye
Return on Assets (TTM)8.91%7.07%Dr. Agarwal's Eye
Free Cash Flow (TTM)$-83.80M$4.94BMax Healthcare
Dividend Yield0.11%0.23%Max Healthcare
1-Year Return4.92%15.42%Max Healthcare
Price-to-Sales Ratio (TTM)5.6414.39Dr. Agarwal's Eye
Enterprise Value$26.43B$1,105.68BMax Healthcare
EV/Revenue Ratio6.3814.72Dr. Agarwal's Eye
Gross Profit Margin (TTM)77.64%78.04%Max Healthcare
Revenue per Share (TTM)$881$77Dr. Agarwal's Eye
Earnings per Share (Diluted)$123.07$11.69Dr. Agarwal's Eye
Beta (Stock Volatility)-0.360.21Dr. Agarwal's Eye
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dr. Agarwal's Eye vs Max Healthcare Stock Performance Analysis

Loading Price Chart...

Dr. Agarwal's Eye
Max Healthcare
Dr. Agarwal's Eye Stock Overview | Max Healthcare Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Agarwal's Eye-0.31%2.98%9.84%14.47%16.54%-23.53%
Max Healthcare-3.95%-4.82%-7.99%-17.84%-4.65%-6.18%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Agarwal's Eye4.92%358.10%1,895.43%3,647.65%6,296.19%14,656.04%
Max Healthcare15.42%157.02%865.85%856.78%856.78%856.78%

News Based Sentiment: Dr. Agarwal's Eye vs Max Healthcare

Dr. Agarwal's Eye

News based Sentiment: POSITIVE

September was a strong month for Dr. Agarwal's, marked by impressive financial results, a commitment to shareholder returns through a 35% dividend, and increasing institutional investor confidence. Long-term projections from Walletinvestor.com further reinforce a positive investment outlook, suggesting significant potential for future growth.

View Dr. Agarwal's Eye News Sentiment Analysis

Max Healthcare

News based Sentiment: MIXED

Max Healthcare experienced a month of strong financial results and positive developments like the Nifty 50 inclusion and 'Buy' ratings. However, a share price decline and some institutional selling create a mixed picture, requiring investors to weigh the opportunities against potential risks.

View Max Healthcare News Sentiment Analysis

Performance & Financial Health Analysis: Dr. Agarwal's Eye vs Max Healthcare

MetricDRAGARWQMAXHEALTH
Market Information
Market Cap i₹23.46B₹1.05T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,4768,434,601
90 Day Avg. Volume i3,3614,395,387
Last Close₹4,950.65₹1,069.20
52 Week Range₹3,500.00 - ₹7,300.00₹888.90 - ₹1,314.30
% from 52W High-32.18%-18.65%
All-Time High₹7,300.00 (Dec 30, 2024)₹1,314.30 (Jul 04, 2025)
% from All-Time High-32.18%-18.65%
Growth Metrics
Quarterly Revenue Growth0.17%0.31%
Quarterly Earnings Growth0.22%0.30%
Financial Health
Profit Margin (TTM) i0.14%0.15%
Operating Margin (TTM) i0.23%0.21%
Return on Equity (TTM) i0.26%0.11%
Debt to Equity (MRQ) i158.9432.09
Cash & Liquidity
Book Value per Share (MRQ)₹445.96₹96.50
Cash per Share (MRQ)₹52.76₹6.81
Operating Cash Flow (TTM) i₹738.70M₹13.02B
Levered Free Cash Flow (TTM) i₹546.50M₹10.76B
Dividends
Last 12-Month Dividend Yield i0.11%0.23%
Last 12-Month Dividend i₹5.00₹3.00

Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye vs Max Healthcare

MetricDRAGARWQMAXHEALTH
Price Ratios
P/E Ratio (TTM) i40.3595.12
Forward P/E i510.8846.14
PEG Ratio i1.813.12
Price to Sales (TTM) i5.6414.39
Price to Book (MRQ) i11.1411.52
Market Capitalization
Market Capitalization i₹23.46B₹1.05T
Enterprise Value i₹26.43B₹1.11T
Enterprise Value Metrics
Enterprise to Revenue i6.3814.72
Enterprise to EBITDA i20.3256.31
Risk & Other Metrics
Beta i-0.360.21
Book Value per Share (MRQ) i₹445.96₹96.50

Financial Statements Comparison: Dr. Agarwal's Eye vs Max Healthcare

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DRAGARWQMAXHEALTH
Revenue/Sales i₹1.17B₹20.28B
Cost of Goods Sold i₹261.40M₹4.45B
Gross Profit i₹907.80M₹15.82B
Research & Development iN/AN/A
Operating Income (EBIT) i₹265.50M₹4.19B
EBITDA i₹379.30M₹5.59B
Pre-Tax Income i₹231.90M₹4.00B
Income Tax i₹59.30M₹924.60M
Net Income (Profit) i₹172.60M₹3.08B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DRAGARWQMAXHEALTH
Cash & Equivalents i₹111.60M₹6.62B
Total Current Assets i₹559.40M₹15.93B
Total Current Liabilities i₹869.80M₹18.14B
Long-Term Debt i₹3.06B₹27.68B
Total Shareholders Equity i₹2.10B₹93.81B
Retained Earnings i₹1.99B₹31.11B
Property, Plant & Equipment i₹1.37B₹19.32B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DRAGARWQMAXHEALTH
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDRAGARWQMAXHEALTH
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,4768,434,601
Average Daily Volume (90 Day) i3,3614,395,387
Shares Outstanding i4.70M972.14M
Float Shares i1.11M683.01M
% Held by Insiders i0.81%0.24%
% Held by Institutions i0.02%0.60%

Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye vs Max Healthcare

MetricDRAGARWQMAXHEALTH
Last 12-Month Dividend i₹5.00₹3.00
Last 12-Month Dividend Yield i0.11%0.23%
3-Year Avg Annual Dividend i₹4.50₹1.33
3-Year Avg Dividend Yield i0.12%0.15%
3-Year Total Dividends i₹13.50₹4.00
Ex-Dividend DateNov 08, 2024Jul 04, 2025